These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32147437)

  • 21. MFN2-dependent recruitment of ATAT1 coordinates mitochondria motility with alpha-tubulin acetylation and is disrupted in CMT2A.
    Kumar A; Larrea D; Pero ME; Infante P; Conenna M; Shin GJ; Grueber WB; Di Marcotullio L; Area-Gomez E; Bartolini F
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered interplay between endoplasmic reticulum and mitochondria in Charcot-Marie-Tooth type 2A neuropathy.
    Bernard-Marissal N; van Hameren G; Juneja M; Pellegrino C; Louhivuori L; Bartesaghi L; Rochat C; El Mansour O; Médard JJ; Croisier M; Maclachlan C; Poirot O; Uhlén P; Timmerman V; Tricaud N; Schneider BL; Chrast R
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2328-2337. PubMed ID: 30659145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HDAC6 inhibitors: Translating genetic and molecular insights into a therapy for axonal CMT.
    Rossaert E; Van Den Bosch L
    Brain Res; 2020 Apr; 1733():146692. PubMed ID: 32006555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MFN2 coordinates mitochondria motility with α-tubulin acetylation and this regulation is disrupted in CMT2A.
    Kumar A; Larrea D; Pero ME; Infante P; Conenna M; Shin GJ; Van Elias V; Grueber WB; Di Marcotullio L; Area-Gomez E; Bartolini F
    iScience; 2024 Jun; 27(6):109994. PubMed ID: 38883841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylation/deacetylation and microtubule associated proteins influence flagellar axonemal stability and sperm motility.
    Chawan V; Yevate S; Gajbhiye R; Kulkarni V; Parte P
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33200789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MFN1 augmentation prevents retinal degeneration in a Charcot-Marie-Tooth type 2A mouse model.
    Shahin S; Lu B; Zhou Y; Xu H; Chetsawang J; Baloh RH; Wang S
    iScience; 2023 Mar; 26(3):106270. PubMed ID: 36936780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction.
    Wattanathamsan O; Chantaravisoot N; Wongkongkathep P; Kungsukool S; Chetprayoon P; Chanvorachote P; Vinayanuwattikun C; Pongrakhananon V
    J Biomed Sci; 2023 Jan; 30(1):4. PubMed ID: 36639650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS.
    Taes I; Timmers M; Hersmus N; Bento-Abreu A; Van Den Bosch L; Van Damme P; Auwerx J; Robberecht W
    Hum Mol Genet; 2013 May; 22(9):1783-90. PubMed ID: 23364049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of histone deacetylase-6 induces contractile dysfunction through derailment of α-tubulin proteostasis in experimental and human atrial fibrillation.
    Zhang D; Wu CT; Qi X; Meijering RA; Hoogstra-Berends F; Tadevosyan A; Cubukcuoglu Deniz G; Durdu S; Akar AR; Sibon OC; Nattel S; Henning RH; Brundel BJ
    Circulation; 2014 Jan; 129(3):346-58. PubMed ID: 24146251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial dynamics and inherited peripheral nerve diseases.
    Pareyson D; Saveri P; Sagnelli A; Piscosquito G
    Neurosci Lett; 2015 Jun; 596():66-77. PubMed ID: 25847151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A.
    Rizzo F; Bono S; Ruepp MD; Salani S; Ottoboni L; Abati E; Melzi V; Cordiglieri C; Pagliarani S; De Gioia R; Anastasia A; Taiana M; Garbellini M; Lodato S; Kunderfranco P; Cazzato D; Cartelli D; Lonati C; Bresolin N; Comi G; Nizzardo M; Corti S
    Cell Mol Life Sci; 2023 Nov; 80(12):373. PubMed ID: 38007410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased α-tubulin acetylation induced by an acidic environment impairs autophagosome formation and leads to rat cardiomyocyte injury.
    Yang L; Zhao L; Cui L; Huang Y; Ye J; Zhang Q; Jiang X; Zhang D; Huang Y
    J Mol Cell Cardiol; 2019 Feb; 127():143-153. PubMed ID: 30582931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel class of anthraquinone-based HDAC6 inhibitors.
    Song Y; Lim J; Seo YH
    Eur J Med Chem; 2019 Feb; 164():263-272. PubMed ID: 30597327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDAC6 Inhibition Corrects Electrophysiological and Axonal Transport Deficits in a Human Stem Cell-Based Model of Charcot-Marie-Tooth Disease (Type 2D).
    Smith AST; Kim JH; Chun C; Gharai A; Moon HW; Kim EY; Nam SH; Ha N; Song JY; Chung KW; Doo HM; Hesson J; Mathieu J; Bothwell M; Choi BO; Kim DH
    Adv Biol (Weinh); 2022 Feb; 6(2):e2101308. PubMed ID: 34958183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
    Noack M; Leyk J; Richter-Landsberg C
    Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A.
    Detmer SA; Vande Velde C; Cleveland DW; Chan DC
    Hum Mol Genet; 2008 Feb; 17(3):367-75. PubMed ID: 17959936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDAC6 inhibition blocks inflammatory signaling and caspase-1 activation in LPS-induced acute lung injury.
    Liu L; Zhou X; Shetty S; Hou G; Wang Q; Fu J
    Toxicol Appl Pharmacol; 2019 May; 370():178-183. PubMed ID: 30910594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone deacetylase 6 inhibition restores autophagic flux to promote functional recovery after spinal cord injury.
    Zheng Z; Zhou Y; Ye L; Lu Q; Zhang K; Zhang J; Xie L; Wu Y; Xu K; Zhang H; Xiao J
    Exp Neurol; 2020 Feb; 324():113138. PubMed ID: 31794745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental defects and neuromuscular alterations due to mitofusin 2 gene (MFN2) silencing in zebrafish: a new model for Charcot-Marie-Tooth type 2A neuropathy.
    Vettori A; Bergamin G; Moro E; Vazza G; Polo G; Tiso N; Argenton F; Mostacciuolo ML
    Neuromuscul Disord; 2011 Jan; 21(1):58-67. PubMed ID: 20951042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.